IBDEI1BJ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21315,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,21315,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,21316,0)
 ;;=I35.9^^70^913^74
 ;;^UTILITY(U,$J,358.3,21316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21316,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,21316,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,21316,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,21317,0)
 ;;=I21.4^^70^913^73
 ;;^UTILITY(U,$J,358.3,21317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21317,1,3,0)
 ;;=3^NSTEMI Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,21317,1,4,0)
 ;;=4^I21.4
 ;;^UTILITY(U,$J,358.3,21317,2)
 ;;=^5007088
 ;;^UTILITY(U,$J,358.3,21318,0)
 ;;=I42.8^^70^913^52
 ;;^UTILITY(U,$J,358.3,21318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21318,1,3,0)
 ;;=3^Cardiomypathies NEC
 ;;^UTILITY(U,$J,358.3,21318,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,21318,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,21319,0)
 ;;=I20.8^^70^913^9
 ;;^UTILITY(U,$J,358.3,21319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21319,1,3,0)
 ;;=3^Angina Pectoris NEC
 ;;^UTILITY(U,$J,358.3,21319,1,4,0)
 ;;=4^I20.8
 ;;^UTILITY(U,$J,358.3,21319,2)
 ;;=^5007078
 ;;^UTILITY(U,$J,358.3,21320,0)
 ;;=I42.2^^70^913^68
 ;;^UTILITY(U,$J,358.3,21320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21320,1,3,0)
 ;;=3^Hypertrophic Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,21320,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,21320,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,21321,0)
 ;;=I35.8^^70^913^75
 ;;^UTILITY(U,$J,358.3,21321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21321,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,21321,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,21321,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,21322,0)
 ;;=I42.5^^70^913^81
 ;;^UTILITY(U,$J,358.3,21322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21322,1,3,0)
 ;;=3^Restrictive Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,21322,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,21322,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,21323,0)
 ;;=I05.8^^70^913^85
 ;;^UTILITY(U,$J,358.3,21323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21323,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,21323,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,21323,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,21324,0)
 ;;=I08.8^^70^913^86
 ;;^UTILITY(U,$J,358.3,21324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21324,1,3,0)
 ;;=3^Rheumatic Multiple Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,21324,1,4,0)
 ;;=4^I08.8
 ;;^UTILITY(U,$J,358.3,21324,2)
 ;;=^5007056
 ;;^UTILITY(U,$J,358.3,21325,0)
 ;;=I47.9^^70^913^79
 ;;^UTILITY(U,$J,358.3,21325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21325,1,3,0)
 ;;=3^Paroxysmal Tachycardia,Unspec
 ;;^UTILITY(U,$J,358.3,21325,1,4,0)
 ;;=4^I47.9
 ;;^UTILITY(U,$J,358.3,21325,2)
 ;;=^5007224
 ;;^UTILITY(U,$J,358.3,21326,0)
 ;;=I05.1^^70^913^82
 ;;^UTILITY(U,$J,358.3,21326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21326,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,21326,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,21326,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,21327,0)
 ;;=I05.0^^70^913^83
 ;;^UTILITY(U,$J,358.3,21327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21327,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,21327,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,21327,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,21328,0)
 ;;=I05.9^^70^913^84
